- Home
- ESQ vs PLRX Comparison
ESQ vs PLRX Comparison
Compare ESQ & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESQ
- PLRX
- Stock Information
- Founded
- ESQ 2006
- PLRX 2015
- Country
- ESQ United States
- PLRX United States
- Employees
- ESQ N/A
- PLRX N/A
- Industry
- ESQ Commercial Banks
- PLRX Biotechnology: Pharmaceutical Preparations
- Sector
- ESQ Finance
- PLRX Health Care
- Exchange
- ESQ Nasdaq
- PLRX Nasdaq
- Market Cap
- ESQ 638.2M
- PLRX 680.3M
- IPO Year
- ESQ 2017
- PLRX 2020
- Fundamental
- Price
- ESQ $87.62
- PLRX $11.77
- Analyst Decision
- ESQ Hold
- PLRX Strong Buy
- Analyst Count
- ESQ 3
- PLRX 7
- Target Price
- ESQ $88.00
- PLRX $40.50
- AVG Volume (30 Days)
- ESQ 113.9K
- PLRX 485.5K
- Earning Date
- ESQ 01-23-2025
- PLRX 02-26-2025
- Dividend Yield
- ESQ 0.81%
- PLRX N/A
- EPS Growth
- ESQ 4.68
- PLRX N/A
- EPS
- ESQ 5.14
- PLRX N/A
- Revenue
- ESQ $120,124,000.00
- PLRX N/A
- Revenue This Year
- ESQ N/A
- PLRX N/A
- Revenue Next Year
- ESQ $10.75
- PLRX N/A
- P/E Ratio
- ESQ $16.70
- PLRX N/A
- Revenue Growth
- ESQ 10.21
- PLRX N/A
- 52 Week Low
- ESQ $44.45
- PLRX $10.22
- 52 Week High
- ESQ $90.18
- PLRX $18.00
- Technical
- Relative Strength Index (RSI)
- ESQ 59.14
- PLRX 47.63
- Support Level
- ESQ $85.34
- PLRX $10.35
- Resistance Level
- ESQ $90.18
- PLRX $11.07
- Average True Range (ATR)
- ESQ 2.79
- PLRX 0.55
- MACD
- ESQ 0.02
- PLRX 0.11
- Stochastic Oscillator
- ESQ 71.79
- PLRX 55.75
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. The Bank operates a payment processing platform through third-party Independent Sales Organizations.
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.